Loading…
Health In Tech, Inc. is projected to rise to $1.15 by 2027, a +3% move from its current price of $1.11. HIT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.07 | $1.11 | $1.15 | -0.03% |
| Aug 6 | $1.06 | $1.11 | $1.16 | -0.07% |
| Aug 7 | $1.05 | $1.11 | $1.17 | -0.10% |
| Aug 8 | $1.04 | $1.11 | $1.18 | -0.13% |
| Aug 9 | $1.03 | $1.11 | $1.19 | -0.17% |
| Aug 10 | $1.02 | $1.11 | $1.20 | -0.20% |
| Aug 11 | $1.02 | $1.11 | $1.21 | -0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.02 | $1.11 | $1.21 | -0.23% |
| Week 2 | $0.9774 | $1.10 | $1.25 | -0.46% |
| Week 3 | $0.9487 | $1.10 | $1.28 | -0.69% |
| Week 4 | $0.9247 | $1.10 | $1.31 | -0.92% |
| Week 5 | $0.9039 | $1.10 | $1.33 | -1.15% |
| Week 6 | $0.8853 | $1.09 | $1.35 | -1.38% |
| Week 7 | $0.8684 | $1.09 | $1.37 | -1.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Health In Tech, Inc. operates as an insurance technology platform company in the United States. It offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers.
Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Health In Tech, Inc. (HIT) is the asset. The current price is $1.04, and the market cap is $68.18M. It ranks 4144. The company operates in the Technology sector.
A major floor 22.0% below — a decisive break under it would weaken the trend.
The nearest floor, 12.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.8% away) — a breakout level to watch.
A major ceiling 64.0% above — clearing it would confirm fresh momentum.
Key HIT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HIT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.08 | Buy | $1.08 | Buy |
| MA 10 | $1.09 | Buy | $1.08 | Buy |
| MA 20 | $1.07 | Buy | $1.07 | Buy |
| MA 50 | $1.03 | Buy | $1.11 | Buy |
| MA 100 | $1.28 | Sell | $1.23 | Sell |
| MA 200 | $1.49 | Sell | $1.52 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.37 | Neutral |
| Stoch RSI (14) | 73.79 | Neutral |
| CCI (20) | 80.48 | Neutral |
| Williams %R (14) | -22.22 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 6.73 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 77.78 | Neutral |
| TRIX (15) | 0.10 | Buy |
| Awesome (5,34) | 0.02 | Buy |
| Ultimate (7,14,28) | 50.71 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 1.07 | Buy |
| ADX (14) | 8.63 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50. Prices are hovering around the short-term moving averages, with SMA50 at $1.03 and SMA200 at $1.50. A defined support level sits near $0.97 and a resistance near $1.13.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.866 | $1.11 | $1.43 | 0% | Neutral | |
| $0.8969 | $1.15 | $1.56 | +3% | Neutral | |
| $0.7981 | $1.05 | $1.50 | -5% | Neutral | |
| $0.9636 | $1.31 | $1.92 | +18% | Neutral | |
| $1.13 | $1.57 | $2.37 | +42% | Bullish | |
| $1.11 | $1.59 | $2.46 | +43% | Bullish | |
| $1.15 | $1.68 | $2.66 | +52% | Bullish | |
| $1.04 | $1.54 | $2.49 | +39% | Bullish | |
| $1.05 | $1.59 | $2.62 | +43% | Bullish | |
| $1.29 | $2.00 | $3.34 | +80% | Bullish | |
| $1.39 | $2.35 | $4.21 | +111% | Bullish | |
| $2.49 | $4.88 | $9.69 | +340% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.866 | $1.11 | $1.36 | +0.00% |
| September 2026 | $0.9412 | $1.12 | $1.37 | +0.86% |
| October 2026 | $0.8979 | $1.08 | $1.34 | -3.81% |
| November 2026 | $0.9009 | $1.09 | $1.37 | +1.01% |
| December 2026 | $0.9262 | $1.13 | $1.43 | +3.45% |
Click any year to see its month-by-month HIT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, HIT is projected to trade between $0.866 and $1.43, averaging $1.11 — a potential gain of 0% from today's $1.11. Price action looks broadly range-bound.
Health In Tech, Inc.'s 2027 outlook centres on $1.15, within a $0.8969 to $1.56 range. That is up +3% on the projected 2026 average. That marks a +3% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, HIT could reach as high as $1.50, with a base case around $1.05 and support toward $0.7981 — roughly -5% from $1.11. Price action looks broadly range-bound.
Expect HIT to range from $0.9636 to $1.92 through 2029. The $1.31 average target implies a +18% move from current prices. That is up +24% on the projected 2028 average. A consolidation phase looks the most probable path here.
The HIT price prediction for 2030 points to an average of $1.57 (low $1.13, high $2.37) — a potential gain of +42% on today's $1.11. Momentum favours further upside here.
In 2031, HIT is projected to trade between $1.11 and $2.46, averaging $1.59 — a potential gain of +43% from today's $1.11. That is up +1% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Health In Tech, Inc.'s 2032 outlook centres on $1.68, within a $1.15 to $2.66 range. That is up +6% on the projected 2031 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2033, HIT could reach as high as $2.49, with a base case around $1.54 and support toward $1.04 — roughly +39% from $1.11. Buyers look set to stay in control over this stretch.
Expect HIT to range from $1.05 to $2.62 through 2034. The $1.59 average target implies a +43% move from current prices. That is up +3% on the projected 2033 average. Momentum favours further upside here.
The HIT price prediction for 2035 points to an average of $2.00 (low $1.29, high $3.34) — a potential gain of +80% on today's $1.11. Buyers look set to stay in control over this stretch.
In 2040, HIT is projected to trade between $1.39 and $4.21, averaging $2.35 — a potential gain of +111% from today's $1.11. That is up +17% on the projected 2035 average. Momentum favours further upside here.
Health In Tech, Inc.'s 2050 outlook centres on $4.88, within a $2.49 to $9.69 range. That is up +108% on the projected 2040 average. That marks a +340% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in HIT today (≈ 900.900901 HIT) could be worth
$4,397.48
+$3,397.48 (+340%) by 2050 · US Dollar
Based on the average projected HIT price of $4.88 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HITwould be worth at today's price.
$1,000 invested in HIT on Jul 31, 2025 (≈ 483.091803 HIT) would be worth
$536.23
-$463.77 (-46.4%) today · 0.54× · US Dollar
Based on a HIT entry price of $2.07 vs. today's $1.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.06 | $1,047.17 | +4.7% |
| 1 month ago | $1.06 | $1,047.17 | +4.7% |
| 3 months ago | $1.55 | $716.13 | -28.4% |
| 6 months ago | $1.12 | $991.07 | -0.9% |
| 1 year ago | $2.07 | $536.23 | -46.4% |
| All time (1.6y) ago | $5.1 | $217.65 | -78.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HIT forecast.
Our base-case forecast reaches $2.20 around 2040.
Implied market cap at $2.20: $118.44M
The multi-year forecast shows a bullish path beginning in 2030 and extending through 2050. In 2026 the avg price is $1.04 with a min of $0.866 and max of $1.33 (ROI 0) and a NEUTRAL sentiment. By 2030 the avg rises to $1.41 with a max of $2.10 and ROI 35.4, and the sentiment shifts to BULLISH.
Through 2031–2035 the avg prices range around $1.43–$1.75 with ROIs from about 33.5 to 68.5. By 2040 the avg is $2.07 (ROI 98.9) and by 2050 the avg reaches $4.22 with a max of $8.18 (ROI 306) and a BULLISH sentiment. These figures illustrate a long-run upside path, but they are estimates and involve uncertainty, including a 2028 min of $0.7479, max $1.38 and a negative short-term year (-5.7 ROI) within the forecast.
Tap a question to reveal the answer.
2030 forecast: avg $1.41, min $1.02, max $2.10; ROI 35.4; sentiment BULLISH.
Forecasted sentiment is NEUTRAL in the near term (through 2029) and BULLISH from 2030 onward, with the 2030 avg $1.41 and 2050 avg $4.22 and ROI up to 306. These are estimates and not guarantees.
Yes. The 2050 forecast lists an avg of $4.22 and a max of $8.18, with a 2050 ROI of 306 and a BULLISH sentiment.
Current price is $1.04. The 30-day range is from $0.8486 to $1.27.
SMA50 is $1.03; SMA200 is $1.50. Support is at $0.97 and resistance is at $1.13.
Health In Tech, Inc. Community Discussion
0Share your Health In Tech, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.